###begin article-title 0
###xml 44 49 <span type="species:ncbi:9606">Human</span>
CD133 Is a Marker of Bioenergetic Stress in Human Glioma
###end article-title 0
###begin p 1
Conceived and designed the experiments: CEG. Performed the experiments: CEG CRO EG PM JRLJ. Analyzed the data: CEG CRO EG PM DJB JRLJ. Contributed reagents/materials/analysis tools: CEG DJB GYG. Wrote the paper: CEG CRO.
###end p 1
###begin p 2
###xml 825 828 825 828 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rho</italic>
###xml 828 829 828 829 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sup>
###xml 836 837 834 835 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sup>
###xml 1008 1009 1004 1005 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sup>
###xml 1193 1194 1187 1188 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sup>
###xml 1331 1332 1323 1324 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sup>
###xml 323 328 <span type="species:ncbi:9606">human</span>
Mitochondria dysfunction and hypoxic microenvironment are hallmarks of cancer cell biology. Recently, many studies have focused on isolation of brain cancer stem cells using CD133 expression. In this study, we investigated whether CD133 expression is regulated by bioenergetic stresses affecting mitochondrial functions in human glioma cells. First, we determined that hypoxia induced a reversible up-regulation of CD133 expression. Second, mitochondrial dysfunction through pharmacological inhibition of the Electron Transport Chain (ETC) produced an up-regulation of CD133 expression that was inversely correlated with changes in mitochondrial membrane potential. Third, generation of stable glioma cells depleted of mitochondrial DNA showed significant and stable increases in CD133 expression. These glioma cells, termed rho0 or rho0, are characterized by an exaggerated, uncoupled glycolytic phenotype and by constitutive and stable up-regulation of CD133 through many cell passages. Moreover, these rho0 cells display the ability to form "tumor spheroids" in serumless medium and are positive for CD133 and the neural progenitor cell marker, nestin. Under differentiating conditions, rho0 cells expressed multi-lineage properties. Reversibility of CD133 expression was demonstrated by transfering parental mitochondria to rho0 cells resulting in stable trans-mitochondrial "cybrid" clones. This study provides a novel mechanistic insight about the regulation of CD133 by environmental conditions (hypoxia) and mitochondrial dysfunction (genetic and chemical). Considering these new findings, the concept that CD133 is a marker of brain tumor stem cells may need to be revised.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 232 235 232 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003655-Griguer1">[1]</xref>
###xml 237 240 237 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003655-Griguer2">[2]</xref>
###xml 242 245 242 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003655-Griguer3">[3]</xref>
###xml 403 406 403 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003655-Warburg1">[4]</xref>
###xml 408 411 408 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003655-ModicaNapolitano1">[5]</xref>
###xml 413 416 413 416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003655-Gillies1">[6]</xref>
###xml 489 492 489 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003655-Galli1">[7]</xref>
###xml 494 497 494 497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003655-Hemmati1">[8]</xref>
###xml 499 502 499 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003655-Singh1">[9]</xref>
###xml 504 508 504 508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003655-Singh2">[10]</xref>
###xml 510 514 510 514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003655-Zheng1">[11]</xref>
###xml 694 697 694 697 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003655-Hemmati1">[8]</xref>
###xml 699 702 699 702 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003655-Singh1">[9]</xref>
###xml 704 708 704 708 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003655-Singh2">[10]</xref>
###xml 710 714 710 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003655-Amuthan1">[12]</xref>
###xml 716 720 716 720 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003655-Bao1">[13]</xref>
###xml 722 726 722 726 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003655-Salmaggi1">[14]</xref>
###xml 941 945 941 945 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003655-Corbeil1">[15]</xref>
###xml 947 951 947 951 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003655-Miraglia1">[16]</xref>
###xml 953 957 953 957 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003655-Yin1">[17]</xref>
###xml 1212 1216 1212 1216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003655-Weigmann1">[18]</xref>
###xml 1258 1262 1258 1262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003655-Shmelkov1">[19]</xref>
###xml 1179 1184 <span type="species:ncbi:10090">mouse</span>
Mitochondria play a major role in many cellular processes including energy production, apoptosis, and generation of free radical species. We previously demonstrated that glioma cell lines relied on mitochondrial energy for survival [1], [2], [3]. Moreover, mitochondrial dysfunction has been linked to an up-regulation of glycolysis, which in turn promotes tumor progression and invasion in all cancers [4], [5], [6]. Brain tumor stem cells have been recently identified and characterized [7], [8], [9], [10], [11]. In particular, a discovery was made that an important cell marker, CD133, that is expressed in non-malignant neural progenitor cells, is also expressed by brain tumor stem cells [8], [9], [10], [12], [13], [14]. CD133, also known as prominin-1, is a member of a family of glycoproteins composed of five transmembrane domains, two cytoplasmic loops, two glycosylated extracellular domains, and a cytoplasmic C-terminal domain [15], [16], [17]. To date, there are no known ligands, no signaling mechanisms have been identified and the functional significance of CD133 remains unknown. However, its localization in membrane protusions, filopodia and lamellipodia of mouse neuroepithelial stem cells [18] suggests a function in membrane topology [19]. The cellular mechanisms involved in the regulation of CD133 remain unknown.
###end p 4
###begin p 5
###xml 453 460 453 460 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 527 531 527 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003655-Ezashi1">[20]</xref>
###xml 790 794 790 794 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003655-Brown1">[21]</xref>
###xml 825 828 825 828 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003655-Griguer1">[1]</xref>
###xml 830 833 830 833 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003655-Gillies1">[6]</xref>
###xml 372 377 <span type="species:ncbi:9606">human</span>
Several lines of evidence suggest that cancer stem cells could play an important role in the initiation, progression, and recurrence of many types of cancer. Thus, it is important to understand how these cells are regulated in the context of tumor progression and therapy. One avenue is a possible common microenvironment and bioenergetic pathway between cancer cells and human embryonic stem (hES) cells. Subsequent to implantation and vascularization in vivo, hES cells are in a hypoxic environment between 1 to 5% of oxygen [20]. Under these conditions, they remain pluripotent. Because hypoxic embryonic cells cannot produce adequate amounts of ATP via mitochondrial oxidative phosphorylation (OxPhos), they rely on anaerobic metabolism to produce ATP to meet their energy requirements [21], just as many cancer cells do [1], [6].
###end p 5
###begin p 6
###xml 305 306 303 304 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sup>
###xml 601 602 597 598 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sup>
###xml 809 810 803 804 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sup>
###xml 124 129 <span type="species:ncbi:9606">human</span>
###xml 690 695 <span type="species:ncbi:9606">human</span>
In this study, we tested the hypothesis that mitochondrial status plays a role in the regulation of the CD133 expression in human glioma cell lines. To this end, we used three cellular models: long term exposure to hypoxia, pharmacologic blockers of the ETC and genetic depletion of mitochondrial DNA (rho0). In all three cellular models, we observed that, regardless of the means used to produce a glycolytic bioenergetic phenotype, CD133 is profoundly up-regulated. Moreover, up-regulation of CD133 expression by hypoxia is reversible upon re-oxygenation. Genetic depletion of mitochondrial DNA (rho0 model) increased CD133 cell surface expression in an irreversible manner and yielded a human glioma model in which CD133 is constitutively expressed. Transfer of mitochondria from parental U251 cells to rho0 cells results in transmitochondrial cybrid clones that manifest parental phenotype. These results strongly demonstrate that mtDNA depletion is at least partly responsible for the CD133 expression.
###end p 6
###begin p 7
Our findings, in combination with the uncertain role of CD133, suggest that the use of CD133 expression as a marker for brain tumor stem cells should be critically evaluated.
###end p 7
###begin title 8
Results
###end title 8
###begin title 9
Expression of CD133 increases in glioma cells maintained under hypoxia
###end title 9
###begin p 10
###xml 422 423 422 423 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 431 438 431 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003655-g001">Fig. 1A</xref>
###xml 534 541 534 541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003655-g001">Fig. 1B</xref>
###xml 1043 1050 1043 1050 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003655-g001">Fig. 1C</xref>
###xml 75 80 <span type="species:ncbi:9606">human</span>
To assess the effect of hypoxia on expression of CD133, we cultured U251MG human glioma cells in 1% oxygen for up to 3 days and compared them to cells maintained under standard normoxic conditions (21% oxygen). Flow cytometric analysis indicated that CD133 expression was not detectable above background when these cells were exposed to 21% oxygen. However, U251MG glioma cells cultured in 1% oxygen were enriched in CD133+ cells (Fig. 1A). Using immunostaining, we confirmed that CD133 labeling was localized in the plasma membrane (Fig. 1B). We then studied whether CD133 expression can be maintained for several days under hypoxic conditions. Cells were grown in 1% oxygen for 3 days, passaged twice and maintained in 1% oxygen for an additional 3 days. Flow cytometry analysis conducted daily during this time period revealed that 40-60% of U251MG cells became labeled with CD133 antibody. Moreover, when cells were returned in 21% oxygen (re-oxygenation), CD133 expression progressively decreased to normoxic levels over the next 3 days (Fig. 1C). These experiments demonstrate that hypoxic conditions increased the CD133 expression by the majority of U251MG glioma cells that normally express a low level of CD133, and that this event was reversible upon re-oxygenation. These findings have been reproduced using the D54MG glioma cell line (data not shown).
###end p 10
###begin title 11
Expression of CD133 in U251 glioma cells under hypoxia.
###end title 11
###begin p 12
A) Flow cytometry histogram of representative U251 cells, with the first peak representing cells negative for CD133-phycoerythrin expression, and the second peak representing CD133 positive cells. Histogram of U251 in 21% oxygen (a) compared with 1% oxygen (b). Data are representative of five similar experiments. B) Immunofluorescence photographs of representative U251 cells grown in 1% oxygen and processed with CD133 antibody (red). Cytoplasm and nucleus were stained with (1 muM) MitoTracker(R) (green) and DAPI (blue) respectively. Arrowhead showing one CD133-negative cell in the field. C) Time-dependent expression of CD133 in glioma cells under hypoxia and reoxygenation. Results are given as means +/- SD of 5 separate experiments. *** represent p<0.001.
###end p 12
###begin title 13
Rotenone treatment enriched CD133 positive glioma cells
###end title 13
###begin p 14
###xml 164 167 164 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003655-Griguer1">[1]</xref>
###xml 169 172 169 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003655-Griguer2">[2]</xref>
###xml 463 470 460 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003655-g002">Fig. 2A</xref>
###xml 524 531 521 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003655-g002">Fig. 2B</xref>
###xml 778 779 769 770 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">s</sub>
###xml 799 806 790 797 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003655-g002">Fig. 2C</xref>
In a recent study, we described that glycolytic glioma cells are resistant to blockers of the ETC, in particular rotenone, a complex I (NADH dehydrogenase) blocker [1], [2]. To determine whether CD133 positive glioma cells became enriched in presence of rotenone, we treated U251MG glioma cells with 1 muM rotenone for up to 3 days under normoxic conditions. Flow cytometric analysis indicated that 37+/-10 % of the cells became labeled with anti-CD133 antibody (Fig. 2A). Induction of CD133 by rotenone was dose-dependent (Fig. 2B). We analyzed the data by Spearman correlation test and by linear regression. Increases in the CD133 positive population after rotenone exposure were significantly correlated with decreases in their mitochondrial membrane potential (DeltaPsim) (rs = 0.82; p<0.0001) (Fig. 2C). These findings have been corroborated using the D54MG glioma cell line (data not shown).
###end p 14
###begin title 15
Rotenone enriched the population of CD133 positive glioma cells.
###end title 15
###begin p 16
A) Time-dependent expression of CD133 in U251 glioma cells exposed to 1 muM rotenone for up to 3 days. B) Dose-dependent regulation of CD133 positive cells. C) Relationship between percentage of CD133 positive cells and DeltaPsim. Data were analyzed by linear regression and p value were calculated using Spearman correlation test. Results are given as means +/- SD of 5 separate experiments. ** represent p<0.001.
###end p 16
###begin title 17
###xml 60 65 <span type="species:ncbi:9606">human</span>
Expression of CD133 increases in mitochondrial DNA depleted human glioma cells
###end title 17
###begin p 18
###xml 39 40 39 40 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sup>
###xml 45 46 43 44 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sup>
###xml 131 135 129 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003655-King1">[22]</xref>
###xml 137 141 135 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003655-Marusich1">[23]</xref>
###xml 143 147 141 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003655-King2">[24]</xref>
###xml 428 429 426 427 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 500 501 496 497 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sup>
###xml 630 639 626 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003655-g003">Figure 3A</xref>
Numerous mtDNA-depleted cell lines (rho0, rho0) have been generated by long-term treatment with very low doses of ethidium bromide [22], [23], [24] in order to study important mitochondrial defects in OxPhos, calcium homeostasis alteration, reactive oxygen species (ROS) production and resistance to apoptosis. In order to test whether loss of mitochondrial function by mtDNA depletion would also up-regulate appearance of CD133+ glioma cells, we generated U251MG mtDNA depleted cells, termed U251rho0. The mtDNA content from U251MG cells cultured with or without EtBr was monitored routinely by amplifying total DNA. As shown in Figure 3A, cytochrome oxidase subunits I (COX I) and II (COX II) which are encoded only in mtDNA were barely amplified from the total DNA of the cells treated with EtBr. In contrast, nuclear DNA encoded COX IV was equally detected in both control and EtBr-treated cells, indicating that prolonged treatment with EtBr selectively depleted mtDNA without altering the nuclear DNA replication in U251MG cells.
###end p 18
###begin title 19
Bioenergetic characterization of mtDNA depleted U251 glioma cells.
###end title 19
###begin p 20
###xml 480 481 478 479 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sup>
###xml 601 602 595 596 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sup>
###xml 648 649 640 641 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sup>
###xml 705 706 695 696 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sup>
A) Genomic DNA was isolated from control and mtDNA-depleted U251 cells, and mtDNA-encoded genes including cytochrome c oxidase subunit I (COX-I) and cytochrome c oxidase subunit II (COX-II) were amplified by PCR. COX IV is used as a nuclear DNA-encoded control. The PCR products were electrophoresed on 1.5% agarose gel and then visualized by EtBr staining. A representative result of three independent experiments is shown. B) Average oxygen consumption rates in U251 and U251rho0. Results are given as means +/- SD of 5 separate experiments. C) Rhodamine123 fluorescence profiles of U251 and U251rho0; NAO fluorescent profiles of U251 and U251rho0. D) Glucose transport activity for the parental and rho0 cells. Results are given as means +/- SD of 3 separate experiments.
###end p 20
###begin p 21
###xml 275 276 273 274 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sup>
###xml 316 317 312 313 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sup>
###xml 415 416 411 412 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 437 438 433 434 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 497 498 487 488 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sup>
###xml 500 507 490 497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003655-g003">Fig. 3B</xref>
After clonogenic selection under ethidium bromide, pyruvate, uridine and 72 serial passages, total oxygen consumption and glucose uptake were measured. Oxygen traces from a Clark electrode showed a time-dependent decrease in oxygen concentration for cell suspensions from rho0 and parental glioma cells. However, rho0 glioma cells consumed significantly less oxygen than the parental cell lines (p<0.005; student's t test) in nmol/min/106 cells: 2.46+/-0.6 versus 0.4+/-0.5 for U251 versus U251rho0 (Fig. 3B).
###end p 21
###begin p 22
###xml 42 43 36 37 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sub>
###xml 147 148 139 140 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sup>
###xml 350 357 342 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003655-g003">Fig. 3C</xref>
###xml 392 393 382 383 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sup>
###xml 554 555 542 543 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sup>
###xml 642 645 630 633 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003655-Griguer1">[1]</xref>
###xml 701 708 689 696 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003655-g003">Fig. 3D</xref>
Mitochondrial membrane potential (DeltaPsim) and mitochondrial mass were assayed by flow cytometry. Decreased incorporation of Rhodamine 123 in rho0 compared to parental cells indicated that mitochondrial function was indeed impaired. Total mitochondrial content, as revealed by cardiolipin detection using nonyl acridine orange, remained unchanged (Fig. 3C). These results indicated that rho0 treatment perturbed mitochondrial function but did not change the quantity of mitochondria. Concomitantly, glucose uptake was significantly increased in U251rho0 compared to U251 (p<0.05; student's t test), which we have shown as a glycolytic type [1], has elevated glucose transporters and glucose uptake (Fig. 3D).
###end p 22
###begin p 23
###xml 61 62 59 60 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sup>
###xml 125 134 123 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003655-g004">Figure 4A</xref>
###xml 161 162 159 160 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 241 242 233 234 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sup>
###xml 540 541 530 531 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sup>
###xml 672 679 662 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003655-g004">Fig. 4B</xref>
###xml 930 934 920 924 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003655-Yu1">[25]</xref>
To determine whether CD133 expression was up-regulated in rho0 glioma cells, we analyzed CD133 expression by flow cytometry. Figure 4A illustrates that the CD133+ glioma cell population increased from 0.5+/-0.02% to 52.40+/-7.54% for U251rho0 cells. This increased level of CD133 expression remained stable for up to 72 passages (data not shown). This finding raised the question of whether expression of CD133 was due to transcription or post-transcription mechanisms. RT-PCR revealed that CD133 mRNA was expressed in both parental and rho0 glioma cells, suggesting that expression of CD133 messenger does not predict cell surface immunoreactivity with CD133 antibodies (Fig. 4B). It seems that expression of the CD133 protein is at least partly regulated at a post-transcriptional level. The relative levels of expression were consistent with that reported for CD133 transcripts in retinoblastoma, lung and colon adenocarcinoma [25].
###end p 23
###begin title 24
###xml 59 60 57 58 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sup>
Anchorage-independent, invasion and CD133 expression in rho0 glioma cells.
###end title 24
###begin p 25
###xml 86 87 84 85 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sup>
###xml 211 212 205 206 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sup>
A) Flow cytometry determination of the percentage of CD133 expressing parental and rho0 cells. Results are given as means +/- SD of 5 separate experiments. B) RT-PCR detection of CD133 mRNA from U251 and U251rho0 glioma cells. Electrophoresis resolved amplicons for CD133 (0.4 kbp) and actin (0.2 kbp) of anticipated sizes. C) Colony formation in soft agar. Results are given as means +/- SD of 3 separate experiments. D) Analysis of invasion into Matrigel 24 h after 5% FCS as chemo-attractant has been added to the lower chamber. *, **, *** represent p<0.05, p<0.005 and p<0.001.
###end p 25
###begin p 26
###xml 229 230 227 228 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sup>
###xml 307 308 303 304 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sup>
###xml 310 317 306 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003655-g004">Fig. 4C</xref>
###xml 329 330 325 326 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 382 383 376 377 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sup>
###xml 464 465 458 459 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 473 480 467 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003655-g004">Fig. 4D</xref>
###xml 528 529 520 521 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sup>
In order to test the potential oncogenic transformation of mtDNA depleted cells, we performed anchorage-independent growth in soft agar and Matrigel invasion assays. Soft-agar plating efficiency was significantly increased in rho0 cells compared to the parental glioma cells (p<0.001 for U251 versus U251rho0; Fig. 4C; student's t test). Matrigel invasion assays showed that U251rho0 are significantly more invasive than the parental U251 cells (p<0.05; student's t test) (Fig. 4D). Taken together; these data indicated that rho0 glioma model depleted of their OxPhos pathways have a more aggressive transformed phenotype than their isogenic counterpart. Essentially, identical findings have been observed with the D54MG glioma cell line (data not shown).
###end p 26
###begin title 27
###xml 7 8 5 6 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sup>
U251rho0 glioma cells harbor properties ascribed to neural and brain tumor stem cells
###end title 27
###begin p 28
###xml 295 299 295 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003655-Rietze1">[26]</xref>
###xml 497 500 497 500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003655-Galli1">[7]</xref>
###xml 502 505 502 505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003655-Hemmati1">[8]</xref>
###xml 507 510 507 510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003655-Singh1">[9]</xref>
###xml 512 516 512 516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003655-Singh2">[10]</xref>
###xml 518 522 518 522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003655-Zheng1">[11]</xref>
###xml 524 528 524 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003655-Bao1">[13]</xref>
###xml 530 534 530 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003655-Blazek1">[27]</xref>
Previous studies described that brain tumor stem cells (BTSCs), as well as their neural stem cell counterparts, are characterized by their ability to form neurospheres in defined serum-free culture medium supplemented with epidermal growth factor (EGF) and basic fibroblast growth factor (bFGF) [26]. Moreover, cells comprising neurospheres expressed nestin and prominin-1 (CD133), neural stem cell markers. Under differentiation conditions, BTSCs expressed markers of neuronal and glial lineages [7], [8], [9], [10], [11], [13], [27].
###end p 28
###begin p 29
###xml 141 145 141 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003655-Rietze1">[26]</xref>
###xml 350 353 350 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003655-Singh1">[9]</xref>
###xml 355 359 355 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003655-Singh2">[10]</xref>
###xml 361 365 361 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003655-Rietze1">[26]</xref>
###xml 390 391 388 389 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sup>
###xml 522 529 520 527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003655-g005">Fig. 5A</xref>
###xml 594 595 590 591 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sup>
###xml 678 685 674 681 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003655-g005">Fig. 5A</xref>
###xml 787 794 783 790 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003655-g005">Fig. 5B</xref>
###xml 913 914 907 908 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sup>
###xml 1052 1053 1044 1045 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sup>
###xml 1172 1181 1161 1170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003655-g005">Figure 5B</xref>
###xml 1220 1221 1207 1208 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sup>
###xml 577 583 <span type="species:ncbi:9913">bovine</span>
We used the culture conditions that favor neural stem cell growth, previously established for isolation of neural stem cells as neurospheres [26]. Neurobasal medium allows for the maintenance of an undifferentiated stem cell state, and the addition of bFGF and EGF induce proliferation of multipotent, self-renewing, and expandable neural stem cells [9], [10], [26]. Within 48-72 h, U251rho0 cultures yielded cells that demonstrated growth into clonally-derived neurosphere-like clusters, which we termed tumor spheroids (Fig. 5A, a). Under DMEM/F12 supplemented with 7% fetal bovine serum, rho0 U251 grows adherently to the plastic substrata and does not form tumor spheroids (Fig. 5A, b). Tumor spheroids retained expression of the classical neural stem cell markers CD133 and nestin (Fig. 5B, a-c, upper panels). We next employed conditions used for neurosphere differentiation to determine whether the U251rho0 were capable of multilineage differentiation. After differentiation with 10% FBS for 7 days, immunocytochemistry was performed on U251rho0 tumor spheroids using antibodies for neuron-specific beta III-tubulin and, astrocyte-specific GFAP. As illustrated in Figure 5B, a-c, lower panels, cells from U251rho0 tumor spheroids exhibited immunoreactivity for both markers indicating multilineage properties.
###end p 29
###begin title 30
###xml 3 4 1 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sup>
rho0 glioma cells form neurosphere-like tumor spheroids expressing neural stem cell markers, nestin and CD133.
###end title 30
###begin p 31
###xml 61 62 59 60 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sup>
###xml 269 270 265 266 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sup>
###xml 421 422 415 416 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sup>
A) Phase contrast microphotographs (magnification X20) of rho0 glioma forming (a) neurosphere-like structures in serumless Neurobasal medium supplement with EGF and FGF after 10 days in culture or (b) adherent culture in DMEM/F12 medium with 7% FBS. B) Spheroids of rho0 cells were immunostained with (b) CD133 or (c) Nestin antibodies or nuclear counterstained with Hoechst 33258 (a). C) Differentiation potential of rho0 tumor spheroids. Multipotency was assayed by immunofluorescence for neuronal (betaIII-tubulin) (a, c) and glial (GFAP) (b a, c) markers.
###end p 31
###begin title 32
Transmitochondrial cybrid cell lines shows parental phenotype
###end title 32
###begin p 33
###xml 213 214 211 212 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sup>
###xml 645 646 641 642 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sup>
###xml 677 684 673 680 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003655-g006">Fig. 6A</xref>
###xml 719 720 713 714 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sup>
In order to further demonstrate that up-regulation of CD133 is a consequence of mtDNA depletion, we repaired the defect by generating cybrid clones in which wild type parental (U251MG) mtDNA was transferred to rho0 cells. Following the enucleation- fusion-selection protocol, six individual surviving cybrid clones were isolated. We selected 2 of these cybrid clones for subsequent analyses that by PCR showed repletion of the mitochondrial encoded cytochrome oxidases COX I and COX II to normal levels compared to U251MG cells. In contrast, nuclear-encoded mitochondrial COX IV remained unchanged in U251MG parental cells, in mtDNA depleted rho0 cells or in the cybrid cells (Fig. 6A). These results indicated that rho0 cells were repopulated with exogenous mtDNA from U251MG parental glioma cells resulting in transmitochondrial cybrids.
###end p 33
###begin title 34
Characterization of U251 transmitochondrial cybrids.
###end title 34
###begin p 35
###xml 446 447 444 445 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sup>
###xml 584 585 580 581 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sup>
###xml 743 744 737 738 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sup>
###xml 816 817 808 809 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sup>
###xml 940 941 930 931 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sup>
###xml 1093 1094 1079 1080 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sup>
A) Genomic DNA was isolated from control, mtDNA-depleted and transmitochondrial cybrid cells, and mtDNA-encoded genes including COX-I and COX-II were amplified by PCR. COX IV serves as a nuclear DNA-encoded control. The PCR products were electrophoresed on 1.5% agarose gel and then visualized by EtBr staining. A representative result of three independent experiments is shown. B) Representative histograms of R123 fluorescence for U251, U251rho0 and cybrids cells (left); average R123 fluorescence profiles (right). C) Representative histograms of NAO fluorescence for U251, U251rho0 and cybrids cells (left); average NAO fluorescence profiles (right). D) A Representative electron transmission microscopy photographs comparing U251, U251rho0 and cybrids cells (Magnification X6000). Arrowhead showing that U251rho0 cells have smaller mitochondria with large intramembraneous spaces. E) Glucose transport activity for the parental and rho0 cells. Results are given as means +/- SD of 3 separate experiments. F) Representative histograms of flow cytometry CD133 fluorescence for U251, U251rho0 and cybrids cells (left). Percentage of CD133 expressing cells (right). Results are given as means +/- SD of 5 separate experiments.
###end p 35
###begin p 36
###xml 239 240 225 226 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sup>
###xml 423 424 405 406 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 432 439 414 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003655-g006">Fig. 6B</xref>
###xml 525 526 505 506 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sup>
###xml 585 586 563 564 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sup>
###xml 806 807 784 785 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 814 821 792 799 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003655-g006">Fig. 6C</xref>
To determine Deltapsim after mtDNA repletion, we exposed living cells to rhodamine 123 which is preferentially taken up by mitochondria. Flow cytometric measurements revealed an increase in Deltapsim in both cybrid clones compared with rho0 cells. Compared with U251MG, a 38+/-1.73% and 40+/-2.54% increase in average fluorescent intensity incorporated into mitochondria was detected in cybrid 1 and cybrid 3 respectively (P<0.005, Fig. 6B). Consonant results were also obtained by flow cytometry with NAO-stained U251MG, rho0 and cybrid cells. The average fluorescence emission in rho0 cells was not markedly different from that in parental U251MG cells. However, 1.97 and 2.84 fold-increases in NAO incorporation were detected in cybrid 1 and cybrid 3, respectively, compared with U251MG parental cells (P<0.05, Fig. 6C).
###end p 36
###begin p 37
###xml 0 9 0 9 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003655-g006">Figure 6D</xref>
###xml 65 66 63 64 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sup>
###xml 193 194 189 190 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sup>
Figure 6D shows electron photomicrographs of parental U251MG, rho0 and cybrid 1 cells. U251MG and cybrid 1 cells both contained homogeneous, elongated mitochondria. In contrast, most of the rho0 cells visualized appeared to have swollen or enlarged mitochondria, showing either complete loss of cristae patterns with empty mitochondrial structure or a disorganized cristae pattern.
###end p 37
###begin p 38
###xml 24 25 22 23 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sup>
###xml 322 329 320 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003655-g006">Fig. 6E</xref>
###xml 337 338 333 334 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sup>
Energy production of rho0 cells completely depends on anaerobic glycolysis and it stands to reason that glucose consumption of cybrid clones should be elevated. Reference values were obtained by examination of U251MG cells, which we have previously defined as largely, but not completely, glycolytic. Glucose consumption (Fig. 6E) of rho0 cells (25+/-2.7 pmol Glc/min/mg protein), however, more than doubled the already increased rate seen in parental U251MG glioma cells (11+/-2.2 pmol Glc/min/mg protein). However, after repairing the mtDNA loss, glucose consumption by the cybrids decreased to values similar to that of U251MG cells (6+/-1.5 and 12+/-1.8 for cybrid 1 and cybrid 3 respectively). Additional evidence of the restoration of mtDNA is the fact that the cybrid clones no longer required supplementation with pyruvate and uridine for survival.
###end p 38
###begin p 39
###xml 29 30 27 28 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sup>
###xml 216 217 212 213 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sup>
###xml 384 391 380 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003655-g006">Fig. 6F</xref>
Cybrid cells derived from rho0 cell lines were stained with fluorochrome-conjugated primary antibodies against CD133 and were analyzed by flow cytometry. FACS analyses indicated that CD133 was highly expressed in rho0 cells but after repair of these mtDNA-depleted cells by fusion with U251MG cytoplasts, the elevation in CD133 expression was reversed to parental U251MG cell levels (Fig. 6F).
###end p 39
###begin title 40
Discussion
###end title 40
###begin p 41
###xml 164 168 164 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003655-Collingridge1">[28]</xref>
###xml 170 174 170 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003655-Evans1">[29]</xref>
###xml 176 180 176 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003655-Rampling1">[30]</xref>
###xml 657 658 657 658 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1109 1112 1109 1112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003655-Gillies1">[6]</xref>
###xml 1114 1118 1114 1118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003655-Frieboes1">[31]</xref>
Hypoxia is a hallmark of glioblastoma multiforme tumors and is believed to promote cancer development, invasive dispersal of tumor cells, and resistance to therapy [28], [29], [30]. Because oxygen is the main substrate of the ETC, hypoxic conditions consequently decreases mitochondrial function and initiates expression of a host of genes that are needed for compensatory ATP production by glycolysis. We showed that glioma cells from long-term established cultures under ambient oxygen (21%) did not express CD133 until they were transferred to severe hypoxia (1% Oxygen) and then maintained their CD133 expression for as long as they were exposed to 1% O2. This CD133 expression on the cell surface was immediate, transient and completely reversible when the cells were returned to ambient oxygen conditions. It is well known that not all tumor cells undergo hypoxia at a fixed time during the formation of the tumor mass. Indeed, chaotic tumor angiogenesis may lead to heterogeneous blood perfusion (blood vessels regressing or collapsing). Thus, the supply of oxygen and/or glucose will likely fluctuate [6], [31], and expression of a "neural stem cell" marker such as CD133 could be transiently expressed as part of the "glycolytic response".
###end p 41
###begin p 42
###xml 321 325 321 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003655-Bao1">[13]</xref>
###xml 336 340 336 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003655-Salmaggi1">[14]</xref>
###xml 475 479 475 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003655-Blazek1">[27]</xref>
###xml 481 485 481 485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003655-Platet1">[32]</xref>
###xml 668 672 668 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003655-Barnhart1">[33]</xref>
###xml 674 678 674 678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003655-Lee1">[34]</xref>
###xml 680 684 680 684 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003655-Semenza1">[35]</xref>
###xml 786 790 786 790 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003655-Ezashi1">[20]</xref>
###xml 723 728 <span type="species:ncbi:9606">human</span>
It is possible that the low incidence of CD133-expressing cells observed in many studies is related to supraphysiologically high oxygen conditions of routine tissue culture. Indeed, we showed that under ambient oxygen less than 3% of U251MG cells expressed CD133. Similarly, low percentages have been described for D54MG [13] and U87MG [14] glioma cells. Two recent studies have described an enriched CD133-positive cell fraction in cells exposed to low oxygen concentration [27], [32]. Therefore, oxygen tension emerges as a main regulator of CD133 expression. Just as hypoxia plays a major role in tumor development, a similar trend is observed during embryogenesis [33], [34], [35]. Indeed, hypoxia is known to maintain human embryonic stem cells (ES) in undifferentiated phenotypes [20]. Upon return to normoxia, ES begin to differentiate.
###end p 42
###begin p 43
###xml 432 435 420 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003655-Griguer2">[2]</xref>
Thus, hypoxia, leading to deprivation of the main electron acceptor, causes perturbation of mitochondrial membrane potential (Deltapsi) and decreases the coupling efficiency between oxidation and phosphorylation. We previously demonstrated that the presence in the culture medium of rotenone, an inhibitor of the respiratory chain Complex I, significantly decreased Deltapsi, without affecting cell viability in U251MG glioma cells [2]. We have shown here that rotenone caused a significant increase in CD133 expression by glioma cells, and this effect was significantly correlated with the inhibition of the mitochondrial membrane potential, demonstrating that mitochondrial function plays a crucial role in the regulation of CD133 expression. However, a definitive and specific role of Complex I in CD133 regulation remains to be elucidated.
###end p 43
###begin p 44
###xml 92 95 92 95 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003655-Warburg1">[4]</xref>
###xml 97 101 97 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003655-Warburg2">[36]</xref>
###xml 438 442 438 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003655-Kallinowski1">[37]</xref>
###xml 444 448 444 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003655-Kania1">[38]</xref>
###xml 805 808 805 808 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003655-Griguer1">[1]</xref>
###xml 810 814 810 814 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003655-Beckner1">[39]</xref>
###xml 816 820 816 820 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003655-Bouzier1">[40]</xref>
The importance of mitochondria in tumor biology has its roots in Warburg's original studies [4], [36]. He postulated that the origin of cancer was due to an irreversible damage of mitochondrial function, leading to enhanced glycolysis. Many studies since then have confirmed increased glycolytic capacity in many malignant tissues, including glioma. However, other studies have demonstrated that cancer cells have functional mitochondria [37], [38]. Our previous study identified several glioma cell lines that were dependent on mitochondrial OxPhos pathway while others were largely dependent on glycolysis. Critically important, glycolytic glioma cells were able to switch energy production to OxPhos in order to survive under limiting glucose conditions, indicating that dual bioenergetic capabilities [1], [39], [40] can be revealed using the appropriate stressors. Thus, mitochondria of glycolytic glioma are functional and essential for survival under low glucose conditions.
###end p 44
###begin p 45
###xml 126 134 126 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
###xml 208 209 206 207 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sup>
###xml 216 220 214 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003655-King1">[22]</xref>
###xml 222 226 220 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003655-King2">[24]</xref>
###xml 228 232 226 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003655-Jazayeri1">[41]</xref>
###xml 237 238 233 234 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sup>
###xml 381 382 375 376 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sup>
###xml 434 435 428 429 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 639 640 631 632 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sup>
###xml 910 914 902 906 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003655-Amuthan1">[12]</xref>
###xml 916 920 908 912 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003655-Shidara1">[42]</xref>
###xml 973 974 963 964 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sup>
###xml 1584 1588 1574 1578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003655-Rietze1">[26]</xref>
###xml 1615 1618 1605 1608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003655-Galli1">[7]</xref>
###xml 1705 1706 1693 1694 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sup>
###xml 112 117 <span type="species:ncbi:9606">human</span>
###xml 863 868 <span type="species:ncbi:9606">human</span>
###xml 984 989 <span type="species:ncbi:9606">human</span>
We initiated this study to investigate the possible link between mitochondria function and tumor progression in human glioma. In vitro, mammalian cells can be depleted of their mitochondrial DNA, creating rho0 cells [22], [24], [41]. rho0 cells lack a functional electron transport chain and appear incapable of generating ATP via the OxPhos mitochondrial pathway. We generated rho0 glioma models that are characterized by decreased O2 consumption, decreased mitochondrial membrane potential and increased glucose uptake. These cells are auxotrophic for uridine and pyruvate and grow quite well without a functional ETC. We showed that rho0 glioma cells developed enhanced anchorage-independent growth and increased invasion phenotypes. These enhanced tumorigenic properties of mtDNA-depleted glioma cells is in accordance with studies reported in mtDNA-depleted human pulmonary carcinoma cells and HeLa cells [12], [42]. To our knowledge, this is the first report of a rho0 model in human glioma. One key feature of this model is the stable expression of CD133. Indeed, the proportion of CD133-expressing cells remains constant during more than 72 serial passages. Moreover, our mtDNA-depleted glioma cells, when grown under defined serumless medium, were able to form tumor spheroids that closely resembled neurospheres that develop under identical conditions from normal neural stem cells. Moreover, mtDNA-depleted glioma cells displayed the capacity for long-term proliferation, self- renewal, and multipotency. All of these properties are classical features of neural stem cells [26] or brain tumor stem cells [7]. The defects in respiratory function following induction of the mtDNA depletion in rho0 glioma cells were reversed by repletion of mtDNA with from enucleated U251MG cytoplasts. Restoration of mitochondrial function in cybrid cells resulted in down-regulation of CD133 expression to parental cell levels. This finding indicates that mitochondrial encoded proteins and their associated functions in the cells play a role in the expression of CD133.
###end p 45
###begin p 46
###xml 113 117 113 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003655-Morange1">[43]</xref>
###xml 318 322 318 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003655-Blagosklonny1">[44]</xref>
###xml 489 492 489 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003655-Gillies1">[6]</xref>
###xml 494 498 494 498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003655-Bissell1">[45]</xref>
###xml 500 504 500 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003655-Liotta1">[46]</xref>
###xml 506 512 506 512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003655-g007">Fig. 7</xref>
###xml 663 666 663 666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003655-Gillies1">[6]</xref>
Our data support a revised model of tumor progression, where epigenetic factors play a critical determinant role [43]. In this tumor progression model, the origin of the first transformed cell is irrelevant but focuses on adaptive biological processes induced in tumor cells through genetic or mitochondrial mutations [44]. This model places a stronger emphasis on the effect of the microenvironment, which is universally recognized has one of the main driving forces of tumor progression [6], [45], [46] (Fig. 7). Our model considers the following factors: (a): nascent tumor cells begin to divide until they have produced nutrient and oxygen diffusion barriers [6]. These cells encounter stringent growth limitation through lack of oxygen and nutrients. A significant fraction of these cells that are close to the most stringent hypoxic microenvironment will have a significant loss of mitochondrial OxPhos function and subsequently switch to glycolysis. This glycolytic switch will trigger expression of stem cell markers such as CD133 and multiple phenotypic changes that result in increased invasion, migration and angiogenesis. (b): increased angiogenesis will result in formation of new vessels that will provide a transient increase in the microenvironment content of oxygen and nutrients allowing the switch from glycolysis back to OxPhos metabolism. (c): because the cells at the margin of tumor invasion will be re-oxygenated, they will grow and divide generating a new oxygen and nutrient diffusion barrier. (d): many such cycles of growth and angiogenesis are repeated during the progression of the tumor. In this model, a feature of the bioenergetically stressed phenotype of glioma cells, as defined by the microenvironment, is expression of CD133. Thus, the number of CD133-positive cells fluctuates, adding a dynamic and transitory dimension to the progression of the tumor.
###end p 46
###begin title 47
Tumor progression model:
###end title 47
###begin p 48
(a) Initiation of tumor formation. (b) Tumor growth restricted at the oxygen and glucose diffusion barrier. (c) Glioma ells at the edge of the tumor will be re-oxygenated by neovascularization, and grow and divide until they reach a new oxygen and nutrient diffusion barrier. (d): repetitive cycles of growth and angiogenesis occur during the progression of the tumor.
###end p 48
###begin p 49
###xml 212 215 212 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003655-Griguer1">[1]</xref>
###xml 217 220 217 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003655-Griguer2">[2]</xref>
###xml 222 226 222 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003655-Bouzier1">[40]</xref>
###xml 228 232 228 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003655-Turcotte1">[47]</xref>
###xml 234 238 234 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003655-Bouzier2">[48]</xref>
###xml 473 477 473 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003655-Sakariassen1">[49]</xref>
Another feature of this microenvironment driven phenotype accommodation that validates this model, is the capacity of glioma cells to switch bioenergetic pathways as has been demonstrated by our group and others [1], [2], [40], [47], [48]. Glioma cells that constitute the bulk of the progressively growing tumor need be extremely plastic, resistant to cell death in unfavorable growth conditions, but most at all, opportunistic of their environment, as has been suggested [49]. Glioma cells with this capability represent a functionally unique subpopulation of cancer cells that manifest "cancer stem cell" properties. The difficulty in designing more efficient therapies lies in understanding how these subpopulations of cells respond to these microenvironmental challenges by engaging different survival pathways.
###end p 49
###begin p 50
A critically important observation from our study is that metabolic flexibility is necessary and essential for tumor progression in glioma. Induction of two opposing phenotypes in cells of identical genetic background demonstrates the plasticity, multipotency and opportunistic properties of these tumors. It suggests that malignant glioma cells are capable of adapting to and remodeling their microenvironment, switching phenotypic behavior to improve their chances for survival. We understand the outcome of becoming more invasive to move to a more hospitable microenvironment, but the expression and function of classic stem cell markers, nestin and CD133, as survival attributes is less clear.
###end p 50
###begin p 51
###xml 403 408 <span type="species:ncbi:9606">human</span>
We described here that hypoxia and modification of the bioenergetic status of glioma cells govern the regulation of CD133 at post-transcriptional level. Data presented here strongly indicated that changes in the cellular environment that results in alteration of mitochondrial function are responsible for the enhanced up-regulation of CD133 antigen in glioma cells, suggesting that CD133 expression in human glioma cells is not obligatory relative to the stem cell phenotype but rather, reveals the occurrence of a stress response.
###end p 51
###begin title 52
Materials and Methods
###end title 52
###begin title 53
Cell and culture and hypoxia treatment
###end title 53
###begin p 54
###xml 359 367 359 367 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in-vitro</italic>
###xml 400 401 400 401 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 503 504 503 504 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 284 290 <span type="species:ncbi:9913">bovine</span>
Human glioma cell lines U251-MG and D54-MG were originally obtained from Dr. D.D. Bigner (Duke University, Durham, NC). Parental U251-MG and D54-MG cells were cultured using 50:50 mixture of DMEM and Ham's nutrient mixture F12 (MediaTech) supplemented with 7% heat- inactivated fetal bovine serum (HyClone) and 2.6 mmol/L L-glutamine. Cells were treated with in-vitro hypoxia for up to 7 days at 1% O2 in a hypoxia chamber (Coy, Laboratory). For re-oxygenation experiments, cells were returned to 21 % O2 for the designated period of time. All chemicals were purchased from Sigma Chemical Co. (St. Louis, MO), unless otherwise stated.
###end p 54
###begin title 55
Staining of mitochondria
###end title 55
###begin p 56
Glioma cells were plated in 12-well plates and cultured for 24 h. Cell monolayers were harvested using trypsin-EDTA (Gibco), washed with Dulbecco's PBS and stained with mitochondrial fluorescent dyes 10-N-nonyl-Acridin Orange (NAO, 1 muM) or Rhodamine 123 (R123, 5 muM) for flow cytometric analysis. After 15 min at 37degreesC, samples were washed once with 2% FCS/PBS to remove unbound dyes, resuspended in 2% FCS/PBS with 2 mug/ml of propidium iodide to allow exclusion of dead cells by FACS. Flow cytometry was performed using a FACSCalibur (Becton Dickinson) and analyzed with FlowJo software (Tree Star, Inc.). Each analysis included at least 20,000 events.
###end p 56
###begin title 57
Flow cytometric analysis for CD133
###end title 57
###begin p 58
###xml 624 625 623 624 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Glioma cells were incubated in cell staining buffer containing biotin-conjugated anti-AC133/1 antibody (Miltenyi Biotec) followed by incubation with Streptavidin-APC-Cy5.5. Isotype-matched immunoglobulin served as controls. Cells were incubated for 20 min at each step and were washed with 2% FCS/PBS between steps. After staining, cells were resuspended in 2% FCS/PBS with 2 mug/ml of propidium iodide to identify dead cells. Two-color flow cytometric analyses were performed using a FACScalibur (Becton Dickinson) and FlowJo software (Tree Star, Inc). Each analysis included at least 25,000 events. The percentage of CD133+ cells present was assessed after correction for the percentage of cells reactive with an isotype control.
###end p 58
###begin title 59
Immunocytochemical staining of CD133 glioma cells
###end title 59
###begin p 60
Cells were cultured on 12 mm poly-lysine coated glass cover slides. After treatment, cells were incubated in staining buffer containing biotin-conjugated anti-AC133/1 antibody (Miltenyi Biotec) followed by incubation with Alexa Fluor 555 streptavidin. Cells were incubated for 20 min at each step and were washed with 2% FCS/PBS between steps. After staining cells were fixed with 4% paraformaldehyde (15 min, room temp) and rinsed 3 times with D-PBS. Cells were nuclear counterstained with 4'6-diamidino-2-phyenylindole (DAPI), washed and mounted in Fluormount G (Southern Biotechnology Associates) and viewed with a Leica/Leitz DMRB fluorescence microscope equipped with appropriate excitation and emission filter sets (Chromatechnology). Images were acquired with a C5810 series digital color camera (Hamamatsu Photonic System). Images were processed with Adobe Photo Shop and IP LAB Spectrum software (Signal Analytics Software).
###end p 60
###begin title 61
Reverse Transcription-Polymerase Chain Reaction Analysis of CD133
###end title 61
###begin p 62
###xml 203 207 203 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003655-Kania1">[38]</xref>
Total RNA was extracted using RNeasy Micro Kit (Qiagen). Reverse transcriptase polymerase chain reaction (RT-PCR) was performed on cDNA using primers specific for CD133 and actin as previously described [38]. PCR products were run on 2% agarose gel with ethidium bromide and visualized using the Eagle Eye Gel reader (Stratagene).
###end p 62
###begin title 63
###xml 46 47 44 45 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sup>
Generation of mtDNA depleted glioma cells (rho0 cells)
###end title 63
###begin p 64
U251-MG and D54-MG cells were cultured in 50 ng/ml Ethidium bromide in DMEM/F12 supplemented with 7% FBS, 1 mmol/L pyruvate and 50 mug/ml uridine. Cells were seeded at low density onto 6 well plates and individual colonies propagated and screened for uridine and pyruvate auxotrophy. Cells were passage twice a week and medium changed every other day.
###end p 64
###begin title 65
Oxygen Consumption Measurements
###end title 65
###begin p 66
###xml 69 70 69 70 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 298 302 292 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003655-Papandreou1">[50]</xref>
###xml 492 493 486 487 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
Cells from triplicate cultures were trypsinized and suspended at 1x106 cells/ml in DMEM/ F12 supplemented with 7% FBS. Oxygen consumption was measured in a 1-ml volume gas-tight vessel thermostatted at 37degreesC, equipped with a Clark type oxygen electrode (Hansatech Instrument Ltd) as described [50]. The data were exported to a computerized chart recorder (Oxygraph 1.01, Hansatech, Instrument Ltd), which calculated the rate of oxygen consumption expressed as nmol oxygen consumed/min/106 cells. Carbonyl cyanide methoxy phenylhydrasone (FCCP), a mitochondrial uncoupler was used to assay maximal oxygen consumption rate.
###end p 66
###begin title 67
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">14</sup>
14C-2-deoxy-D-glucose (DOG) uptake
###end title 67
###begin p 68
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">14</sup>
###xml 150 153 150 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003655-Griguer1">[1]</xref>
14[C]-DOG was purchased from Amersham Biosciences (Piscataway, NJ) (61 mCi/mmol). Uptake experiments were carried out as we have described previously [1].
###end p 68
###begin title 69
Anchorage independent clonogenic assay
###end title 69
###begin p 70
###xml 90 96 <span type="species:ncbi:9913">bovine</span>
Glioma cells (2,000) previously mixed with 0.45% agar-DMEM/F12 supplemented with 7% fetal bovine serum were seeded on a 0.9% agar cushion. Cells were fed every 5 days with DMEM/F12. After 3 weeks, the colonies were fixed with PBS-formalin, stained with Giemsa and counted.
###end p 70
###begin title 71
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
In vitro invasion assay
###end title 71
###begin p 72
###xml 144 145 143 144 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 357 363 <span type="species:ncbi:3635">cotton</span>
Cell invasion assays were conducted in BD BioCoat matrigel invasion transwell chambers with 8.0-mum pore membranes (BD Biosciences). Cells (4x104) in 500 muL culture medium were added to the upper chamber. The bottom chambers contained 800 muL culture medium supplemented with 7% FCS as a chemoattractant. At 24 h later, the upper membranes were wiped with cotton swabs and any cells that had migrated to the bottom side of the membranes were fixed in ice-cold methanol. Hematoxylin and eosin staining was performed and membranes were excised, placed on microscope slides. Cells in five random visual fields (100x magnification) were counted for each membrane. All experiments were done in triplicates.
###end p 72
###begin title 73
Transmitochondrial cybrid generation
###end title 73
###begin p 74
###xml 104 108 104 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003655-Zieve1">[51]</xref>
###xml 110 114 110 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003655-Peek1">[52]</xref>
###xml 365 366 356 357 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sup>
###xml 38 43 <span type="species:ncbi:9606">human</span>
###xml 437 440 <span type="species:ncbi:9685">cat</span>
To obtain transmitochondrial cybrids, human U251MG glioma cells were enucleated as previously described [51], [52]. Briefly, cells were treated with cytochalasin B (10 mug/ml) and then layered on a Ficoll step gradient. After centrifugation at 37degreesC for 90 minutes at 130,000 g cytoplasmic fractions were collected. The cytoplasts were then fused with U251 rho0 cells by adding a solution of 50% polyethylene glycol (MW 1450, Sigma cat P-5402) in phosphate buffer. Cybrids were plated and continuously grown in DMEM/F12 medium supplemented with 7% dialyzed FBS. Two weeks after fusion, cybrids were plated at low density for clonogenic selection.
###end p 74
###begin title 75
Transmission electron microscopy
###end title 75
###begin p 76
###xml 131 135 129 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003655-Lewis1">[53]</xref>
Electron photomicrographs for parental U251MG, U251 rho0 and transmitochondrial cybrid cells were prepared as described previously [53]. Briefly, cell pellets were washed in sucrose/phosphate buffer and fixed in paraldehyde and glutaraldehyde. Pellets were then post-fixed in phosphate-buffered 1% osmium tetroxide. Samples were stained en bloc with 2% uranyl acetate, rinsed, dehydrated, and embedded in Spurr's resin. Thin sections were cut on an Ultracut E ultramicrotome (Reichert-Jung), placed on copper grids, stained with lead citrate, and micrographed with an EM-1200 EX II electron microscope.
###end p 76
###begin p 77
We thank Dr. V.M. Darley-Usmar (University of Alabama at Birmingham) for discussion, advice and critically reading the manuscript.
###end p 77
###begin p 78
In Memory: R. Griguer and S. Benouaich
###end p 78
###begin title 79
References
###end title 79
###begin article-title 80
###xml 36 41 <span type="species:ncbi:9606">human</span>
###xml 46 51 <span type="species:ncbi:10090">mouse</span>
Glucose metabolism heterogeneity in human and mouse malignant glioma cell lines.
###end article-title 80
###begin article-title 81
Pharmacologic manipulations of mitochondrial membrane potential (DeltaPsim) selectively in glioma cells.
###end article-title 81
###begin article-title 82
Xanthine oxidase-dependent regulation of hypoxia-inducible factor in cancer cells.
###end article-title 82
###begin article-title 83
On respiratory impairment in cancer cells.
###end article-title 83
###begin article-title 84
###xml 17 22 <span type="species:ncbi:9606">human</span>
Mitochondria and human cancer.
###end article-title 84
###begin article-title 85
Adaptive landscapes and emergent phenotypes: why do cancers have high glycolysis?
###end article-title 85
###begin article-title 86
###xml 80 85 <span type="species:ncbi:9606">human</span>
Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma.
###end article-title 86
###begin article-title 87
Cancerous stem cells can arise from pediatric brain tumors.
###end article-title 87
###begin article-title 88
###xml 40 45 <span type="species:ncbi:9606">human</span>
Identification of a cancer stem cell in human brain tumors.
###end article-title 88
###begin article-title 89
###xml 18 23 <span type="species:ncbi:9606">human</span>
Identification of human brain tumour initiating cells.
###end article-title 89
###begin article-title 90
Most C6 cells are cancer stem cells: evidence from clonal and population analyses.
###end article-title 90
###begin article-title 91
Mitochondria-to-nucleus stress signaling induces phenotypic changes, tumor progression and cell invasion.
###end article-title 91
###begin article-title 92
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response.
###end article-title 92
###begin article-title 93
Glioblastoma-derived tumorospheres identify a population of tumor stem-like cells with angiogenic potential and enhanced multidrug resistance phenotype.
###end article-title 93
###begin article-title 94
###xml 4 9 <span type="species:ncbi:9606">human</span>
The human AC133 hematopoietic stem cell antigen is also expressed in epithelial cells and targeted to plasma membrane protrusions.
###end article-title 94
###begin article-title 95
A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning.
###end article-title 95
###begin article-title 96
###xml 26 31 <span type="species:ncbi:9606">human</span>
AC133, a novel marker for human hematopoietic stem and progenitor cells.
###end article-title 96
###begin article-title 97
Prominin, a novel microvilli-specific polytopic membrane protein of the apical surface of epithelial cells, is targeted to plasmalemmal protrusions of non-epithelial cells.
###end article-title 97
###begin article-title 98
AC133/CD133/Prominin-1.
###end article-title 98
###begin article-title 99
Low O2 tensions and the prevention of differentiation of hES cells.
###end article-title 99
###begin article-title 100
Control of respiration and ATP synthesis in mammalian mitochondria and cells.
###end article-title 100
###begin article-title 101
###xml 13 18 <span type="species:ncbi:9606">human</span>
Isolation of human cell lines lacking mitochondrial DNA.
###end article-title 101
###begin article-title 102
###xml 107 112 <span type="species:ncbi:9606">human</span>
###xml 234 241 <span type="species:ncbi:9606">patient</span>
Expression of mtDNA and nDNA encoded respiratory chain proteins in chemically and genetically-derived Rho0 human fibroblasts: a comparison of subunit proteins in normal fibroblasts treated with ethidium bromide and fibroblasts from a patient with mtDNA depletion syndrome.
###end article-title 102
###begin article-title 103
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human cells lacking mtDNA: repopulation with exogenous mitochondria by complementation.
###end article-title 103
###begin article-title 104
###xml 28 33 <span type="species:ncbi:9606">human</span>
AC133-2, a novel isoform of human AC133 stem cell antigen.
###end article-title 104
###begin article-title 105
Neural stem cell isolation and characterization.
###end article-title 105
###begin article-title 106
###xml 104 105 104 105 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Daoy medulloblastoma cells that express CD133 are radioresistant relative to CD133- cells, and the CD133+ sector is enlarged by hypoxia.
###end article-title 106
###begin article-title 107
###xml 48 53 <span type="species:ncbi:9606">human</span>
Polarographic measurements of oxygen tension in human glioma and surrounding peritumoural brain tissue.
###end article-title 107
###begin article-title 108
###xml 54 59 <span type="species:ncbi:9606">human</span>
Hypoxia is important in the biology and aggression of human glial brain tumors.
###end article-title 108
###begin article-title 109
###xml 67 72 <span type="species:ncbi:9606">human</span>
Direct measurement of pO2 distribution and bioreductive enzymes in human malignant brain tumors.
###end article-title 109
###begin article-title 110
Computer simulation of glioma growth and morphology.
###end article-title 110
###begin article-title 111
###xml 50 55 <span type="species:ncbi:9606">human</span>
Influence of oxygen tension on CD133 phenotype in human glioma cell cultures.
###end article-title 111
###begin article-title 112
Metastasis and stem cell pathways.
###end article-title 112
###begin article-title 113
###xml 64 69 <span type="species:ncbi:10090">mouse</span>
Determination of hypoxic region by hypoxia marker in developing mouse embryos in vivo: a possible signal for vessel development.
###end article-title 113
###begin article-title 114
Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1.
###end article-title 114
###begin article-title 115
On the origin of cancer cells.
###end article-title 115
###begin article-title 116
###xml 118 123 <span type="species:ncbi:9606">human</span>
Tumor blood flow: the principal modulator of oxidative and glycolytic metabolism, and of the metabolic micromilieu of human tumor xenografts in vivo.
###end article-title 116
###begin article-title 117
Somatic stem cell marker prominin-1/CD133 is expressed in embryonic stem cell-derived progenitors.
###end article-title 117
###begin article-title 118
Glycolytic glioma cells with active glycogen synthase are sensitive to PTEN and inhibitors of PI3K and gluconeogenesis.
###end article-title 118
###begin article-title 119
Glucose and lactate metabolism in C6 glioma cells: evidence for the preferential utilization of lactate for cell oxidative metabolism.
###end article-title 119
###begin article-title 120
Inducible expression of a dominant negative DNA polymerase-gamma depletes mitochondrial DNA and produces a rho0 phenotype.
###end article-title 120
###begin article-title 121
Positive contribution of pathogenic mutations in the mitochondrial genome to the promotion of cancer by prevention from apoptosis.
###end article-title 121
###begin article-title 122
The field of cancer research: an indicator of present transformations in biology.
###end article-title 122
###begin article-title 123
Molecular theory of cancer.
###end article-title 123
###begin article-title 124
Putting tumours in context.
###end article-title 124
###begin article-title 125
The microenvironment of the tumour-host interface.
###end article-title 125
###begin article-title 126
###xml 78 83 <span type="species:ncbi:9606">human</span>
Variation in mitochondrial function in hypoxia-sensitive and hypoxia-tolerant human glioma cells.
###end article-title 126
###begin article-title 127
Compartmentation of lactate and glucose metabolism in C6 glioma cells. A 13c and 1H NMR study.
###end article-title 127
###begin article-title 128
Cancer stem cells as mediators of treatment resistance in brain tumors: status and controversies.
###end article-title 128
###begin article-title 129
HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption.
###end article-title 129
###begin article-title 130
Newly synthesized small nuclear RNAs appear transiently in the cytoplasm.
###end article-title 130
###begin article-title 131
Subcellular distribution of Ro ribonucleoprotein complexes and their constituents.
###end article-title 131
###begin article-title 132
Ultrastructural changes associated with reduced mitochondrial DNA and impaired mitochondrial function in the presence of 2'3'-dideoxycytidine.
###end article-title 132
###begin p 133
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 133
###begin p 134
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: American Brain Tumor Association (C.E.G.) and a Career Development Award from the UAB Brain Tumor SPORE (C.E.G.), U.S. Public Health Service NIH grant P50CA97247 and P01 CA 071933 (G.Y.G.), NIH research grants HL074391 and HL71189 (J.R.L., Jr.) and NIH research grant CA101952 (D.J.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 134

